Buy VIROPACE (MESTEROLONE Tablets) 25mg Online

Description

Chemical name: 1α-Methyl-17β-hydroxy-[5α]-androstan-3-one
Formula: C20H3O2
Anabolic activity index: 150%
Androgenic activity index: 40%

Introduction: Viropace is a pharmaceutical product manufactured by Concern Pharma, containing the active substance Mesterolone. It is available in the form of oral tablets, with each pack containing 10 pills, and each pill containing 25 mg of Mesterolone. Viropace is primarily used to treat conditions associated with testosterone deficiency in men and to improve certain male health parameters.

1. Mechanism of Action: Mesterolone, the active ingredient in Viropace, is a synthetic derivative of dihydrotestosterone (DHT) with mild androgenic properties. It acts by binding to androgen receptors in various tissues, including muscle and bone, exerting androgenic effects similar to those of natural testosterone. Mesterolone also has weak estrogenic activity, which may contribute to its therapeutic effects in certain conditions.

2. Indications: Viropace is indicated for the following purposes:

• Testosterone Deficiency: It is used to treat hypogonadism and androgen deficiency syndromes in men, where the body fails to produce sufficient testosterone.
• Male Infertility: Viropace may be prescribed to improve sperm production and fertility in men with oligospermia (low sperm count) or other fertility issues.
• Androgen-related Disorders: It can also be used to manage symptoms of androgen-related disorders such as delayed puberty and erectile dysfunction.

3. Dosage and Administration:

• The dosage of Viropace may vary depending on the specific indication, severity of the condition, and individual response to the medication.
• It is typically administered orally, with a recommended dosage ranging from 25 mg to 100 mg per day for adult men.
• Viropace tablets should be taken with a full glass of water and may be taken with or without food, as directed by a healthcare provider.

4. Precautions:

• Viropace should be used with caution in individuals with a history of prostate disorders, liver dysfunction, or cardiovascular disease.
• It is contraindicated in women, especially pregnant or breastfeeding women, due to the risk of virilization (development of male characteristics).
• Regular monitoring of prostate-specific antigen (PSA) levels and liver function tests may be necessary during treatment with Viropace.

5. Side Effects:

• Common side effects of Viropace may include acne, oily skin, hair loss, increased body hair growth, and mood changes.
• More serious side effects such as liver toxicity, prostate enlargement, and cardiovascular complications may occur with higher dosages or prolonged use.

6. Manufacturer:

• Viropace is manufactured by Concern Pharma, a reputable pharmaceutical company known for producing high-quality medications and adhering to strict quality standards.

7. Conclusion: Viropace tablets (Mesterolone) manufactured by Concern Pharma are indicated for the treatment of testosterone deficiency, male infertility, and certain androgen-related disorders in men. With its androgenic and estrogenic effects, Viropace offers therapeutic benefits for men experiencing hormonal imbalances and related symptoms. Patients considering Viropace should consult with their healthcare provider to determine if it is suitable for their individual needs and to discuss any potential risks or side effects.